Navigation Links
Xanodyne Pharmaceuticals Appoints New Chief Operating Officer
Date:5/17/2011

NEWPORT, Ky. and MOUNT ARLINGTON, N.J., May 17, 2011 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc., is pleased to announce that Fabrice Egros has been appointed to the position of Chief Operating Officer reporting to Natasha Giordano, President and Chief Executive Officer.

Fabrice Egros has more than 20 years of experience in the pharmaceutical industry and prior to Xanodyne served in various senior positions in UCB Pharmaceuticals (Belgium, US and Japan).  His depth of experience includes senior leadership positions in general management, corporate business development, clinical development & regulatory as well as marketing and sales in Europe, Asia and the US at major pharmaceutical companies including Sanofi-Aventis and Parke-Davis.

Mr. Egros said, "I look forward to working with Natasha and the management team in continuing to drive toward our vision of being a leader in the pain management category.  Xanodyne has a proven track record of bringing innovative products to the market and developing strategic partnerships where desired, as well as the people, resources and strategy to focus Xanodyne on high growth opportunities within the pain franchise."  

Ms. Giordano said, "I am very pleased to welcome Fabrice to our management team.  His global knowledge of the industry, deep experience in corporate development and his strong leadership will help us achieve our strategic goals and commercial success in pain management."

About Xanodyne Pharmaceuticals, Inc.

Xanodyne Pharmaceuticals, Inc., founded in 2001, is an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management. Xanodyne markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins.  Additionally, we are advancing a late stage pipeline of product candidates targeted at significant potential markets in Xanodyne's focus area.  For more information, visit www.Xanodyne.com.


'/>"/>
SOURCE Xanodyne Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Xanodyne Agrees to Withdraw Propoxyphene From the U.S. Market
2. Xanodyne Announces Planned President & CEO Succession
3. Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
4. Xanodyne Announces Renewed Focus on Pain Management Market
5. Xanodyne Expands U.S. Sales Force and Launches Zipsor(TM) (diclofenac potassium) Liquid Filled Capsules
6. Xanodyne Raises $50 Million in Equity Financing to Support Emerging Product Portfolio
7. Access Pharmaceuticals Provides Update on MuGard Commercial Activities
8. Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011
9. Amylin Pharmaceuticals Files Suit Against Eli Lilly
10. Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
11. Reportlinker Adds Pharmaceuticals Reports Bundle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Cirujanos holandeses han puesto en ... médicos a compartir sus mejores prácticas por el mundo ... médicos de Europa, África, Asia ... aplicación, que combina la transmisión en vivo con mensajería ... Educación   "Imagine un médico de Medicines ...
(Date:5/24/2016)... , May 24, 2016  Diana Russell suffers ... her organs from the inside out.  This disease has ... dependent on her children and grandchildren to leave her ... wheelchair, Diana,s family cannot haul the wheelchair.  So if ... the car, and Diana is left to wait for ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... With long-term experience in ... of Business Intelligence and Informatics, effective immediately. http://www.fluidedgeconsulting.com , As a ... a healthcare business and financial strategist for over 20 years. By leveraging ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... Get With The Guidelines®-Stroke Gold Plus Achievement Award with Target: StrokeSM Honor ... Healthcare System, recognizes its commitment to emergency stroke care to ensure that ...
(Date:5/25/2016)... City, MO (PRWEB) , ... May 25, 2016 , ... ... collegiate, and amateur athletics, The National Center for Drug Free Sport (Drug Free Sport®) ... Free Sport”. This conference, to be held July 12 – 13 in Kansas City, ...
(Date:5/25/2016)... ... May 25, 2016 , ... According to an ... of hernia mesh that would effectively fight against common bacteria and protect against surgical ... healing process from hernia repair surgery even safer and could further reduce ...
(Date:5/25/2016)... ... ... The Bank of America Charitable Foundation has awarded a grant to the General ... employment and successful careers in healthcare. On Wednesday, May 4th, Rick Bridwell, Bank of ... Medisend, parent organization and home of the General Myers Veterans Program. , “The ...
Breaking Medicine News(10 mins):